Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04620096 · ClinicalTrials.gov registry record

MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis

A clinical trial, sponsored by University of Washington.

Completed
Registry status
74
Enrollment target

NCT04620096 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 74 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04620096 has completed, sponsored by University of Washington.

COMPLETED
Registry status
74 participants
Enrollment target

Study Summary

Cystic fibrosis (CF) affects men and women equally, but after the onset of puberty, women with CF have a lower life expectancy than men with CF. Despite these known differences, the link between CF symptom trends and the menstrual cycle remains critically understudied. To address this gap, this study will investigate changes in CF-specific symptoms among women with CF to evaluate whether and how they correlate with their menstrual cycle. Specifically, the investigators hope to examine whether CF-related symptoms change throughout the menstrual cycle, what the impact of those symptoms is on quality of life, and how feasible it is to use a period tracking app to track CF-related symptoms throughout the menstrual cycle. Investigators are asking women ages 18-45 with CF, who have regular menstrual cycles, to participate. Study procedures, including online surveys, period tracking, and interview, will take approximately 3 months.

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2021-06-01
Est. Completion 2022-04-22

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT04620096

The ClinicalTrials.gov registry entry for NCT04620096 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04620096 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04620096 about?

NCT04620096 is a clinical study titled "MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis". Cystic fibrosis (CF) affects men and women equally, but after the onset of puberty, women with CF have a lower life expectancy than men with CF. Despite these known differences, the link between CF symptom trends and the menstrual cycle remains critically understudied. To address this gap, this stud...

What is the current status of trial NCT04620096?

This trial is currently completed. The enrollment target is 74 participants. The study started on 2021-06-01. Estimated completion is 2022-04-22.

Who is sponsoring clinical trial NCT04620096?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.